Canaccord Genuity Group Issues Pessimistic Forecast for Prestige Consumer Healthcare (NYSE:PBH) Stock Price

by · The Markets Daily

Prestige Consumer Healthcare (NYSE:PBH – Get Free Report) had its price objective lowered by stock analysts at Canaccord Genuity Group from $72.00 to $70.00 in a research note issued on Friday, Benzinga reports. The brokerage currently has a “buy” rating on the stock. Canaccord Genuity Group‘s price objective suggests a potential upside of 61.18% from the stock’s previous close.

Several other equities research analysts have also recently weighed in on PBH. Weiss Ratings restated a “sell (d+)” rating on shares of Prestige Consumer Healthcare in a report on Tuesday, September 22nd. Zacks Research cut Prestige Consumer Healthcare from a “strong-buy” rating to a “hold” rating in a research note on Thursday, October 29th. One investment analyst has rated the stock with a Buy rating, three have issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, Prestige Consumer Healthcare currently has a consensus rating of “Hold” and an average price target of $67.00.

Read Our Latest Report on Prestige Consumer Healthcare

Prestige Consumer Healthcare Trading Down 2.0%

Prestige Consumer Healthcare stock traded down $0.89 during mid-day trading on Friday, hitting $43.43. The company’s stock had a trading volume of 628,739 shares, compared to its average volume of 567,253. The company has a debt-to-equity ratio of 1.06, a current ratio of 3.23 and a quick ratio of 1.99. The stock has a market cap of $2.06 billion, a price-to-earnings ratio of 12.17, a price-to-earnings-growth ratio of 1.67 and a beta of 0.30. The business has a 50 day moving average price of $48.34 and a 200-day moving average price of $53.88. Prestige Consumer Healthcare has a 12 month low of $41.77 and a 12 month high of $71.07.

Prestige Consumer Healthcare (NYSE:PBH – Get Free Report) last announced its quarterly earnings data on Thursday, November 5th. The company reported $1.13 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.07 by $0.06. The firm had revenue of $336.31 million for the quarter, compared to analysts’ expectations of $329.14 million. Prestige Consumer Healthcare had a return on equity of 11.39% and a net margin of 15.57%. The company’s revenue for the quarter was up 22.7% compared to the same quarter last year. During the same period last year, the firm earned $1.07 earnings per share. As a group, analysts forecast that Prestige Consumer Healthcare will post 4.56 EPS for the current year.

Institutional Inflows and Outflows

Several institutional investors have recently added to or reduced their stakes in the stock. BlackRock Inc. bought a new stake in shares of Prestige Consumer Healthcare during the 2nd quarter valued at about $370,187,000. Rice Hall James & Associates LLC purchased a new position in shares of Prestige Consumer Healthcare in the 2nd quarter valued at approximately $32,602,000. The Manufacturers Life Insurance Company bought a new stake in shares of Prestige Consumer Healthcare during the second quarter valued at approximately $31,135,000. Bank of America Corp DE bought a new stake in shares of Prestige Consumer Healthcare during the second quarter valued at approximately $26,277,000. Finally, Bank of New York Mellon Corp purchased a new stake in Prestige Consumer Healthcare in the second quarter worth $15,376,000. 99.95% of the stock is currently owned by institutional investors.

About Prestige Consumer Healthcare

(Get Free Report)

Prestige Consumer Healthcare Inc (NYSE: PBH) is a consumer healthcare company that develops, acquires, markets and distributes over-the-counter health and wellness products. Its portfolio is focused on established brands designed to address everyday healthcare needs, including digestive health, eye and ear care, oral care, pain relief, cold and allergy symptoms, feminine care and dermatological conditions.

The company’s brands include Dramamine and Bonine for motion-sickness relief; BC and Goody’s for pain relief; Clear Eyes and Murine for eye and ear care; Chloraseptic for sore-throat relief; Compound W for wart removal; Fleet for gastrointestinal health; and Summer’s Eve for feminine care.

Recommended Stories